Dark

Check out our Level2View

BRRGF
ONCOINVENT ASA
stock OTC

Inactive

Jun 8, 2021

3.50USD-0.568%(-0.02)400

Pre-market

0.00USD-100.000%(-3.52)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jun 11, 2021

03:36AM EDT Bergenbio Presents Encouraging Updated Preliminary Data From Phase Ii Study In PR Newswire

Dec 6, 2020

02:23PM EST BerGenBio Presents Updated Clinical Data From Two Phase II Studies Of PR Newswire

Nov 11, 2020

08:24AM EST BerGenBio Presents Phase II Bemcentinib Combination Study In NSCLC RTTNews

08:20AM EST BerGenBio Presents Phase II Bemcentinib Combination Study in NSCLC at Annual PR Newswire

Oct 23, 2020

01:16AM EDT BerGenBio Virtual R&D Day - 06 November 2020 PR Newswire

Sep 1, 2020

01:20AM EDT BerGenBio to Present at Upcoming Investor Conferences PR Newswire

Aug 18, 2020

01:44AM EDT BerGenBio Reports Q2 Operating Loss Widens To NOK 64.7 Mln From NOK 52.0 Mln Last Year RTTNews

01:30AM EDT BerGenBio ASA: Results for the Second Quarter and First Half of 2020 PR Newswire

Aug 10, 2020

01:18AM EDT BERGENBIO ASA: Invitation to second quarter 2020 results webcast presentation PR Newswire

Share